Characteristics and Clinical Outcomes of Individuals at High Risk for Pancreatic Cancer: A Descriptive Analysis from a Comprehensive Cancer Center release_whsdlcsknnb5zcrw6hsbuvupua

by Griffin McNamara, Karla Ali, Shraddha Vyas, Tri Huynh, Monica Nyland, Deanna Almanza, Christine Laronga, Jason Klapman, Jennifer Permuth

Published in Gastrointestinal Disorders by MDPI AG.

2018   Volume 1, Issue 1, p106-119


Pancreatic cancer (PC), a leading cause of cancer-related deaths in the United States, is typically diagnosed at an advanced stage. To improve survival, there is an unmet need to detect pre-malignant lesions and early invasive disease. Prime populations to study for early detection efforts include cohorts of high risk individuals (HRI): those with increased risk to develop pre-malignant pancreatic cysts and PC because of a familial or hereditary predisposition to the disease and those in the general population of sporadic cases who are incidentally found to harbor a pre-malignant pancreatic cyst. The objective of this study was to describe the characteristics and clinical outcomes of cohorts of HRI identified at Moffitt Cancer Center. We set out to determine the uptake of screening, the prevalence and characteristics of solid and cystic pancreatic lesions detected via screening or as incidental findings, and the age at which lesions were detected. Of a total of 329 HRI, roughly one-third were found to have pancreatic lesions, most of which constituted pre-malignant cysts known as intraductal papillary mucinous neoplasms. Individuals with the highest genetic risk for PC were found to have smaller cysts at a much earlier age than sporadic cases with incidental findings; however, many individuals at high genetic risk did not have abdominal imaging reports on file. We also identified a subset of HRI at moderate genetic risk for PC that were found to have cystic and solid pancreatic lesions as part of a diagnostic work-up rather than a screening protocol. These findings suggest the pancreatic research community should consider expanding criteria for who should be offered screening. We also emphasize the importance of continuity of care between cancer genetics and gastrointestinal oncology clinics so that HRI are made aware of the opportunities related to genetic counseling, genetic testing, and screening.
In application/xml+jats format

Archived Files and Locations

application/pdf  795.0 kB
file_6ui2wxqfcveqla72v2tm2xoccq (publisher) (webarchive)
Read Archived PDF
Type  article-journal
Stage   published
Date   2018-11-01
Language   en ?
Container Metadata
Open Access Publication
In Keepers Registery
ISSN-L:  2624-5647
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: f507f857-7c7a-4933-89ef-24ed927551d9